Health

HEALTH • Summer 2016 7 Clinton Hospital | HealthAlliance Hospital | Marlborough Hospital | UMass Memorial Medical Center At UMass Memorial Health Care, you'll find hundreds of caring, compassionate and skilled adult and pediatric primary care physicians across Central Massachusetts. And because our doctors are part of the region's premier health care system, access to a wide range of specialty care and our nationally recognized academic medical center is only a referral away. To find a UMass Memorial primary care physician near you, call 855-UMASS-MD (855-862-7763). I WANT IT ALL I want convenience I want compassion I want world-class care said Dr. Janet Wright, executive director of Million Hearts. VA orders 20 ReWalk exoskeletons MARLBOROUGH — The U.S. Department of Veterans Affairs (VA) purchased an additional 20 ReWalk exoskeleton units from the Marlborough company to support initiation of its national multicenter clinical trial. The purchase of 20 Personal 6.0 exoskeleton systems, which allow people with certain spi- nal injuries to walk upright rather than sit in a wheel chair, will be in addition to six units already provid- ed by ReWalk. The 160-person, four- year long, multi-center study is being undertaken to evaluate the impact of exoskeleton use in a home or daily life setting. The study will start in October. BSX gets FDA approval M A R L B O R O U G H — Marlborough's Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for two catheters that can be used with the company's Rhythmia Mapping System to generate a 3-D map of a patient's heart to help diagnose, locate and treat the source of rhythm abnormality. These are the first mag- netically tracked catheters that Boston Scientific will offer to the U.S. market. Along with the immedi- ate launch of the catheters, the com- pany is also releasing a software enhancement for the Rhythmia Mapping System that will allow for faster mapping of the heart. Boston Scientific recalls blood clot-removal device B oston Scientific, the Marlborough medical device manufacturer and developer, announced a voluntary worldwide recall of a device used to remove small blood clots from coronary arteries during thrombectomy pro- cedures. The Fetch 2 Aspiration Catheter was recalled March 22 after the company received complaints of shaft breakage during operations. The worst-case scenario of the breakage is either surgery to recover the fragments or an embolism of device fragments, which could lead to obstruction of blood flow, accord- ing to the company. No reports of patient injury or death have been filed. Southcoast Health in $2B merger with Rhode Island co. CHARLTON — SouthCoast Health and Care New England last November announced plans to study a partnership and now the non-profit hospital and health care systems' boards have voted to move forward with a $2-billion affiliation featuring eight hospitals and more than 15,000 employees. The health care companies plan to operate an integrated system, and are set now to work out an affiliation agree- ment and embark upon required regu l ator y pro cess es in Massachusetts and Rhode Island. Southcoast Health includes Charlton Memorial Hospital in Fall River, St. Luke's Hospital in New Bedford and Tobey Hospital in Wareham, as well as Southcoast Behavioral Health in Dartmouth. Marlborough co. to add 100 jobs in expansion MARLBOROUGH — CeQur has broken ground on an expansion of its Marlborough facility that will double its size and allow it to increase the workforce by 100 over the next two years. The maker of simple insulin infusion for people with diabetes is undertaking the expansion in prepa- ration for the launch of the compa- ny's three-day insulin infusion device, PAQ. When work is completed later this year, it will bring the facility's size to 25,000 square feet, according to a release from CeQur. The expansion includes a new clean room, labs and a manufacturing line. The new space will also allow the company to grow its Marlborough employee base from 50 to 150, according to an announce- ment. Marlborough co. gets FDA approval for laser heart treatment Continued on Page 27

• Cover